Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease (Q51171610)

31 March 2018

title

Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease (English)

1 reference

31 March 2018

chronic obstructive pulmonary disease

main subject

1 reference

1 reference

31 March 2018

author name string

Hironi Makita

1 reference

31 March 2018

Katsura Nagai

1 reference

31 March 2018

Satoshi Konno

1 reference

31 March 2018

Yasuyuki Nasuhara

1 reference

31 March 2018

Masaru Hasegawa

1 reference

31 March 2018

Kaoruko Shimizu

1 reference

31 March 2018

Tomoko Betsuyaku

1 reference

31 March 2018

Yoichi M Ito

1 reference

31 March 2018

Satoshi Fuke

1 reference

31 March 2018

Takeshi Igarashi

1 reference

31 March 2018

Yasushi Akiyama

1 reference

31 March 2018

Shigeaki Ogura

1 reference

31 March 2018

Hokkaido COPD Cohort Study Investigators

1 reference

31 March 2018

language of work or name

English

0 references

publication date

1 January 2012

1 reference

31 March 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

31 March 2018

volume

185

1 reference

31 March 2018

issue

1 reference

31 March 2018

page(s)

44-52

1 reference

31 March 2018

The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Pathophysiology of airflow limitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

CT-quantified emphysema in male heavy smokers: association with lung function decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Association of radiographic emphysema and airflow obstruction with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Quantitative computed tomography of lung parenchyma in chronic obstructive pulmonary disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

COPD exacerbations .1: Epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Pulmonary emphysema: objective quantification at multi-detector row CT--comparison with macroscopic and microscopic morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Predictors of mortality in patients with emphysema and severe airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Efficacy of tiotropium in COPD patients from Asia: A subgroup analysis from the UPLIFT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Impact of Exacerbations on Emphysema Progression in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

Computed tomography in pulmonary emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201106-0992OC

10.1164/RCCM.201106-0992OC

21 January 2018

Identifiers

DOI

1 reference

31 March 2018

1 reference

31 March 2018